Melanie McCullagh

BVF, Inc. manages engages in investment business and manages biotech focused hedge funds. The firm manages Biotechnology Value Fund LP and Biotechnology Value Fund II LP. The company was founded by Mark Nathan Lampert on September 14, 1993 and is headquartered in San Francisco, CA.

BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts.

Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY.

ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.

Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA.

Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Part of Sosei Group Corp., Sosei Co. Ltd. is a world-leader in GPCR medicine design and development. The company is based in Tokyo, Japan. The Japanese company obtains and maintains intellectual property rights to protect its innovations and technologies.

Part of Dassault Systèmes SA, Synomics Ltd. implements software primarily for the biological and pharmaceutical industry. The company is based in Cambridge, UK. Peter Juul Kristensen has been the CEO of the British company since 2020. Synomics was acquired by BIOVIA, Inc., part of Dassault Systèmes SA from April 30, 2014 on June 29, 2001 for $3.50 million.

Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA.

General Electric Canada Co. manufactures and markets products for the generation and distribution of electricity. It offers aircraft engines, power generation, water processing, and security technology to medical imaging, business & consumer financing, and media content. The company was founded by Thomas Edison in 1892 and is headquartered in Mississauga, Canada.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom.

Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Juvenile Diabetes Research Foundation Ltd. is a British company that engages in the prevention, treatment, causes, and cure for diabetes. The CEO of the non-profit company is Karen Addington.

Aquilo Capital Management LLC (Aquilo) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. Aquilo was founded in 2010 to manage investment funds and separately managed accounts for individual clients.

Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom.

Linaro Ltd. is a collaboration platform for the Arm partnership. The non-profit company is based in Cambridge, UK. The British company provides a space where members can collaborate on Arm Open Source Software and solutions. The company was founded in 2010. Gong Li has been the CEO of the company since 2019.

Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.

Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom.

BVF Partners OS Ltd. provides real estate services.

Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom.

OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom.

Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom.